These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1145487)

  • 41. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of programmed hemodialysis on the absorptive-excretory function of the liver in terminal chronic renal insufficiency].
    Kozyr' VI
    Vrach Delo; 1975 Jun; (6):41-3. PubMed ID: 1154735
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma aldosterone in patients with end stage kidney disease.
    Weidmann P; Lupu AN; Schroth P; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
    [No Abstract]   [Full Text] [Related]  

  • 45. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
    Nikiforova NV; Sokolovskaia IV
    Ter Arkh; 1980; 52(4):55-7. PubMed ID: 7404338
    [No Abstract]   [Full Text] [Related]  

  • 46. Response of peripheral plasma renin activity (PRA) to furosemide stimulation; reduction of the renal parenchyma as a limiting factor.
    Zabka J; Stríbrná J; Rotnáglová Z
    Physiol Bohemoslov; 1981; 30(5):397-403. PubMed ID: 6459589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The crythrocyte system in terminal renal failure caused by chronic glomerulonephritis, treated by hemodialysis].
    Dobiecka-Wawrzecka B
    Wiad Lek; 1980 Jun; 33(11):849-54. PubMed ID: 7423987
    [No Abstract]   [Full Text] [Related]  

  • 48. [Central hemodynamic indices of patients with chronic kidney failure treated by hemodialysis].
    Pevzner AS; Fedorov VV; Voronina EO; D'iachuk MM; Konstantinov IuV
    Vrach Delo; 1989 Jan; (1):14-6. PubMed ID: 2718433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical studies of hypertension in chronic glomerulonephritis. 2. Hypertension in the uremic phase: relationship between hemodynamic changes and plasma renin activity during hemodialysis].
    Nishio I
    Nihon Jinzo Gakkai Shi; 1974 Jan; 16(1):20-32. PubMed ID: 4471777
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma concentrations of astemizole in patients with terminal renal insufficiency, before, during and after hemodialysis.
    Zazgornik J; Scholz N; Heykants J; Vanden Bussche G
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):246-8. PubMed ID: 2874116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the hemodynamic response to hemodialysis with acetate or bicarbonate.
    Schick EC; Idelson BA; Liang C; Redline RC; Bernard DB
    Trans Am Soc Artif Intern Organs; 1983; 29():25-8. PubMed ID: 6324441
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hemodialysis of patients in terminal renal insufficiency].
    Enger E; Halvorsen S
    Tidsskr Nor Laegeforen; 1971 May; 91(15):1139-54. PubMed ID: 4934913
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of hemodialysis on endothelin-1 plasma levels in children with terminal renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Popović-Rolović M; Adanja G; Parezanović V; Pariović V; Jovanović I; Kostić M; Jovanović O; Kruscić D
    Srp Arh Celok Lek; 1996; 124 Suppl 1():92-4. PubMed ID: 9102944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemodialysis and hypertension].
    Fukuchi S; Takeuchi T; Nakajima K; Tsuchida S; Sugawara H
    Nihon Rinsho; 1972 Dec; 30(12):2470-7. PubMed ID: 4347356
    [No Abstract]   [Full Text] [Related]  

  • 55. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment].
    Neĭmark MI
    Ter Arkh; 1984; 56(9):102-5. PubMed ID: 6569758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Zinc in patients with chronic renal insufficiency subjected to periodic maintenance hemodialysis].
    Temes-Montes XL; Picaporte MA; Herrero E; Otero A; Sánchez-Guisande D; Sánchez-Sicilia L
    Rev Clin Esp; 1982 May; 165(3):189-91. PubMed ID: 7134531
    [No Abstract]   [Full Text] [Related]  

  • 58. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)].
    Loutocký A; Lachmanová J; Tomásek R; Horký K
    Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974
    [No Abstract]   [Full Text] [Related]  

  • 59. [Plasmatic renin activity in patients in chronic intermittent haemodialysis program and after renal transplantation (author's transl)].
    Karlícek V; Topolcan O; Opatrný K; Podzimek A; Novák V
    Cas Lek Cesk; 1974 Jan; 113(2):33-7. PubMed ID: 4611626
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy of terminal renal insufficiency].
    Hallauer W
    Med Klin; 1974 Apr; 69(14):561-73. PubMed ID: 4600334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.